Chronic Granulomatous Disease is the most commonly encountered immunodeficiency involving the phagocyte, and is characterized by repeated infections with bacterial and fungal pathogens, as well as the formation of granulomas in tissue. The disease is the result of a disorder of the NADPH oxidase system, culminating in an inability of the phagocyte to generate superoxide, leading to the defective killing of pathogenic organisms. This can lead to infections with Staphylococcus aureus, Psedomonas species, Nocardia species, and fungi (such as Aspergillus species and Candida albicans). Involvement of vital or large organs can contribute to morbidity and/or mortality in the affected patients. Major advances have occurred in the diagnosis and treatment of this disease, with the potential for gene therapy or stem cell transplantation looming on the horizon. © 2011 Song et al; licensee BioMed Central Ltd.
CITATION STYLE
Song, E. K., Jaishankar, G. B., Saleh, H., Jithpratuck, W., Sahni, R., & Krishnaswamy, G. (2011, May 31). Chronic granulomatous disease: A review of the infectious and inflammatory complications. Clinical and Molecular Allergy. https://doi.org/10.1186/1476-7961-9-10
Mendeley helps you to discover research relevant for your work.